Yuval Cohen - Jan 26, 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Chief Executive Officer, Director
Signature
/s/ Yuval Cohen
Stock symbol
CRBP
Transactions as of
Jan 26, 2024
Transactions value $
$0
Form type
4
Date filed
1/30/2024, 04:56 PM
Previous filing
Aug 11, 2022
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRBP Common Stock Options Exercise $35.7K +7.18K $4.97 7.18K Jan 26, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Options to purchase common stock Options Exercise -$35.7K -7.18K -100% $4.97 0 Jan 26, 2024 Common stock 7.18K $4.97 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.